Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Milena Gnjidić"'
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss 3., Pp 496-504 (2020)
Germ-cell testicular cancer (GCTC) is a malignant neoplasm derived from the primordial germ cell. Although it accounts for approximately 1% of all malignancies in men, it is the most common cancer of younger male population, with the highest incidenc
Externí odkaz:
https://doaj.org/article/47b8f68942644cb6b3bd7601e01d9be4
Autor:
Matea Pešorda, Sanja Kusačić Kuna, Dražen Huić, Davorin Herceg, Marija Despot, Tatjana Samardžić, Milena Gnjidić, Borislav Belev
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss Supplement 1, Pp 73-79 (2020)
Although most patients with thyroid cancer have a favorable clinical course, some patients develop a more aggressive type of cancer and exhibit more rapid disease progression with worse prognosis. Those patients usually exhibit mutations of protein
Externí odkaz:
https://doaj.org/article/d77b374894f941d693d79e115571a129
Autor:
Marija Despot, Davorin Herceg, Borislav Belev, Dražen Huić, Sanja Kusačić Kuna, Matea Pešorda, Milena Gnjidić, Tatjana Samardžić
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss Supplement 1, Pp 73-79 (2020)
Acta clinica Croatica
Volume 59.
Issue Supplement 1
Acta Clinica Croatica
Acta clinica Croatica
Volume 59.
Issue Supplement 1
Acta Clinica Croatica
Although most patients with thyroid cancer have a favorable clinical course, some patients develop a more aggressive type of cancer and exhibit more rapid disease progression with worse prognosis. Those patients usually exhibit mutations of proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16afe8b3a5d2a8d235a1253bcb72e735
https://hrcak.srce.hr/file/360861
https://hrcak.srce.hr/file/360861
Publikováno v:
Croatian Medical Journal
Atezolizumab is a monoclonal antibody immune checkpoint inhibitor that binds to programmed death ligand 1 to selectively prevent its interaction with programmed cell death-1 (PD-1) and B7.1 (CD80) receptors. We present a case of a 61-year-old man wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddb91c34fd51edb84d9484d18b92e95
https://doi.org/10.3325/cmj.2019.60.552
https://doi.org/10.3325/cmj.2019.60.552
Publikováno v:
Libri Oncologici Croatian Journal of Oncology. 47:48-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4b49e23c94394394e584fa72a2b5c38
https://doi.org/10.20471/lo.2019.47.02-03.09
https://doi.org/10.20471/lo.2019.47.02-03.09
Publikováno v:
Libri Oncologici Croatian Journal of Oncology. 47:71-73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6202ccb07e318017ce19e39516d5282f
https://doi.org/10.20471/lo.2019.47.02-03.13
https://doi.org/10.20471/lo.2019.47.02-03.13
Publikováno v:
Acta Clinica Croatica
Acta Clinica Croatica, Vol 59., Iss 3., Pp 496-504 (2020)
Acta clinica Croatica
Volume 59.
Issue 3.
Acta Clinica Croatica, Vol 59., Iss 3., Pp 496-504 (2020)
Acta clinica Croatica
Volume 59.
Issue 3.
Germ-cell testicular cancer (GCTC) is a malignant neoplasm derived from the primordial germ cell. Although it accounts for approximately 1% of all malignancies in men, it is the most common cancer of younger male population, with the highest incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0b522303ec187ded6071c5f9f9a908
https://doi.org/10.20471/acc.2020.59.03.14
https://doi.org/10.20471/acc.2020.59.03.14
Autor:
Ana Marija Alduk, Dragan Trivanović, Mislav Čonkaš, Ana Tečić Vuger, Natalija Dedić Plavetić, Robert Šeparović, Damir Vrbanec, Ljubica Vazdar, Milena Gnjidić, Irma Gorsić, Željko Vojnović, Mirjana Pavlović, Gordana Horvatić-Herceg, Juraj Prejac
Publikováno v:
Liječnički vjesnik
Volume 140
Issue 3-4
Volume 140
Issue 3-4
Rak je drugi najvažniji uzrok smrti u našoj zemlji, odmah nakon bolesti srca i krvnih žila. S pretpostavkom porasta incidencije i smrtnosti od raka u idućim godinama, projekcije su da će se znatno povisiti i troškovi dijagnostike i liječenja r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f127316cffd22f800d61ea0944dbf12
https://doi.org/10.26800/lv-140-3-4-8
https://doi.org/10.26800/lv-140-3-4-8
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 47
Issue 2-3
Volume 47
Issue 2-3
Field of metastatic renal cell cancer (mRCC) treatments is now evolving at a rapid and unprecedented pace. Nivolumab prolongs survival in patients with metastatic kidney cancer with a favorable safety profile as demonstrated in the Check-Mate 025 cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::3c6806a7ce86f57e4ab3396d838dfa1a
https://hrcak.srce.hr/233608
https://hrcak.srce.hr/233608
Autor:
Ana Marija Alduk, Damir Miletić, Maja Drežnjak Madunić, Valdi Pešutić Pisac, Milena Gnjidić, Stela Bulimbašić, Marija Gamulin, Mislav Čonkaš, Marijana Jazvić, Nikola Knežević, Tomislav Sorić, Tomislav Omrčen, Marijan Šitum
Publikováno v:
Liječnički vjesnik. 141
Testicular tumors are the most common solid tumors in men between age 15- 34 years. The worldwide incidence of these tumors has doubled in the past 40 years. Germ cell tumors comprise 95% of malignant tumors arising in the testes and they are classif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75890ce1d0a29a35b7cb67325db743a3
https://doi.org/10.26800/lv-141-11-12-44
https://doi.org/10.26800/lv-141-11-12-44